Company Overview of Tempero Pharmaceuticals, Inc.
Tempero Pharmaceuticals, Inc. develops medicines for the treatment of autoimmune diseases. It develops therapies that selectively prevent Th17-driven diseases, or enhance the development of specialized Treg subsets. Its products treat autoimmune disorders, such as multiple sclerosis, inflammatory bowel disease, psoriasis, and type 1 diabetes. The company was founded in 2009 and is based in Cambridge, Massachusetts.
200 Technology Square
Cambridge, MA 02139
Founded in 2009
Key Executives for Tempero Pharmaceuticals, Inc.
Similar Private Companies By Industry
|BioIncept LLC||United States|
|Proneuron Biotechnologies, Inc.||United States|
|Cardinal Health 404, Inc.||United States|
|Takeda Vaccines (Montana), Inc.||United States|
|Spectra Stable Isotopes||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Tempero Pharmaceuticals, Inc., please visit www.temperopharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.